Total Payments
$7,620
2024 Payments
$57.77
Companies
13
Transactions
36
Medicare Patients
14,562
Medicare Billing
$4.1M
Payment Breakdown by Category
Other$5,350 (70.2%)
Travel$1,109 (14.6%)
Food & Beverage$1,105 (14.5%)
Gifts$33.70 (0.4%)
Education$22.29 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,350 | 7 | 70.2% |
| Travel and Lodging | $1,109 | 3 | 14.6% |
| Food and Beverage | $1,105 | 23 | 14.5% |
| Gift | $33.70 | 1 | 0.4% |
| Education | $22.29 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $6,682 | 14 | $0 (2022) |
| Janssen Biotech, Inc. | $311.95 | 3 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $122.98 | 1 | $0 (2022) |
| Cardinal Health 110 LLC | $119.21 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $115.64 | 7 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $88.64 | 1 | $0 (2023) |
| Genentech USA, Inc. | $46.21 | 3 | $0 (2017) |
| Genmab U.S., Inc. | $34.02 | 1 | $0 (2024) |
| Welch Allyn | $33.70 | 1 | $0 (2020) |
| Tempus AI, Inc | $23.75 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.77 | 2 | Genmab U.S., Inc. ($34.02) |
| 2023 | $214.63 | 2 | Janssen Biotech, Inc. ($125.99) |
| 2022 | $1,649 | 9 | AstraZeneca Pharmaceuticals LP ($1,313) |
| 2021 | $4,004 | 6 | AstraZeneca Pharmaceuticals LP ($3,900) |
| 2020 | $1,484 | 4 | AstraZeneca Pharmaceuticals LP ($1,450) |
| 2018 | $18.93 | 1 | Janssen Pharmaceuticals, Inc ($18.93) |
| 2017 | $191.47 | 12 | Novartis Pharmaceuticals Corporation ($115.64) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.75 | General |
| 03/01/2024 | Genmab U.S., Inc. | — | Food and Beverage | In-kind items and services | $34.02 | General |
| 09/20/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $125.99 | General |
| Category: Oncology | ||||||
| 01/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $88.64 | General |
| 12/11/2022 | Cardinal Health 110 LLC | — | Food and Beverage | In-kind items and services | $119.21 | General |
| 12/11/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $69.26 | General |
| 09/07/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $93.65 | General |
| Category: Oncology | ||||||
| 05/21/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Travel and Lodging | In-kind items and services | $461.35 | General |
| Category: Oncology | ||||||
| 05/21/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Travel and Lodging | In-kind items and services | $281.99 | General |
| Category: Oncology | ||||||
| 05/20/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Travel and Lodging | In-kind items and services | $365.34 | General |
| Category: Oncology | ||||||
| 05/20/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Oncology | ||||||
| 05/20/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Oncology | ||||||
| 04/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $122.98 | General |
| 09/21/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $92.31 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/19/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Oncology | ||||||
| 05/18/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 05/18/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 05/18/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Oncology | ||||||
| 12/10/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Oncology | ||||||
| 07/27/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: Oncology | ||||||
| 07/01/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Oncology | ||||||
| 05/06/2020 | Welch Allyn | None (Device) | Gift | In-kind items and services | $33.70 | General |
| Category: Not Applicable | ||||||
| 10/04/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2017 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 79 | 4,380 | 109,172 | $3.2M | $1.2M |
| 2022 | 82 | 3,962 | 122,351 | $4.0M | $1.4M |
| 2021 | 75 | 3,519 | 85,387 | $2.7M | $993,879 |
| 2020 | 63 | 2,701 | 33,757 | $1.5M | $522,185 |
Total Patients
14,562
Total Services
350,667
Medicare Billing
$4.1M
Procedure Codes
299
All Medicare Procedures & Services
299 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 21 | 6,202 | $589,000 | $268,421 | 45.6% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2023 | 14 | 5,580 | $474,300 | $211,721 | 44.6% |
| J9299 | Injection, nivolumab, 1 mg | Office | 2023 | 17 | 7,014 | $385,770 | $166,591 | 43.2% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 27 | 3,050 | $271,450 | $116,418 | 42.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 31 | 3,960 | $166,320 | $70,010 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 621 | $136,620 | $59,526 | 43.6% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 78 | 162 | $100,764 | $27,651 | 27.4% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 29 | 27,750 | $111,000 | $24,421 | 22.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 149 | 245 | $88,445 | $24,249 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 134 | $39,798 | $18,603 | 46.7% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 21 | 7,740 | $68,140 | $18,068 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 271 | $40,108 | $17,223 | 42.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 268 | 1,117 | $34,627 | $11,552 | 33.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 312 | 1,291 | $25,456 | $10,801 | 42.4% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 49 | 7,800 | $62,400 | $10,701 | 17.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 313 | 1,366 | $31,418 | $10,389 | 33.1% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 85 | 179 | $84,488 | $8,459 | 10.0% |
| J9041 | Injection, bortezomib, 0.1 mg | Office | 2023 | 17 | 1,635 | $129,165 | $7,316 | 5.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 36 | 115 | $23,115 | $6,446 | 27.9% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 54 | 182 | $14,014 | $6,346 | 45.3% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 24 | 29 | $19,488 | $5,909 | 30.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 90 | 116 | $21,228 | $5,674 | 26.7% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 116 | 448 | $26,880 | $5,306 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $11,844 | $4,790 | 40.4% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 48 | 85 | $14,790 | $4,216 | 28.5% |
About Dr. Steven Duffy, MD
Dr. Steven Duffy, MD is a Internal Medicine healthcare provider based in East Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1154586188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Duffy, MD has received a total of $7,620 in payments from pharmaceutical and medical device companies, with $57.77 received in 2024. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,350).
As a Medicare-enrolled provider, Duffy has provided services to 14,562 Medicare beneficiaries, totaling 350,667 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 299 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Syracuse, NY
- Active Since 07/18/2008
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154586188
Products in Payments
- LYNPARZA (Drug) $5,350
- CALQUENCE (Drug) $1,244
- DARZALEX (Biological) $311.95
- TASIGNA (Drug) $37.53
- AFINITOR (Drug) $34.96
- None (Device) $33.70
- RYDAPT (Drug) $29.18
- FASLODEX (Drug) $19.25
- XARELTO (Drug) $18.93
- Avastin (Biological) $18.37
- Perjeta (Biological) $13.98
- KISQALI (Drug) $13.97
- GAZYVA (Biological) $13.86
- Onivyde (Drug) $10.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Syracuse
Ajeet Gajra, Md, MD
Internal Medicine — Payments: $87,892
Internal Medicine $87,892
Dr. Robert Cupelo, M.d, M.D
Internal Medicine — Payments: $33,179
Internal Medicine $33,179
Brian Raphael, M.d, M.D
Internal Medicine — Payments: $10,696
Internal Medicine $10,696
Dr. Suhayb Kadura, M.d, M.D
Internal Medicine — Payments: $3,921
Internal Medicine $3,921
Michael Brodowski, M.d, M.D
Internal Medicine — Payments: $2,994
Internal Medicine $2,994
Dr. Diana Christensen, Md, MD
Internal Medicine — Payments: $1,814
Internal Medicine $1,814